Drug Delivery System For The Prevention Of Cerebral Vasospasm
AssigneeEdge Therapeutics, Inc.
InventorsR. Loch Macdonald, Brian Leuthner
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm.
Claims42
A method of treating a cerebral vasospasm in a human, the method comprising the steps:
- a) providing a pharmaceutical composition;
- b) administering a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space;
- c) wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm.
A method of treating a human for vasospasm after subarachnoid hemorrhage in at least one cerebral artery, the method comprising the steps of:
- a) providing a pharmaceutical composition;
- b) administering a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space;
- c) wherein the pharmaceutical composition produces a localized therapeutic effect thereby treating the vasospasm.
The method of claim 182, wherein the therapeutic agent is a transient receptor potential protein blocker.
A pharmaceutical composition for administration into the subarachnoid space for treating cerebral vasospasm in a human comprising
- a) a therapeutically effective amount of a therapeutic agent;
- and
- b) a pharmaceutical carrier.
Dependencies are inferred from the claim text.